Copson E - Search Results

1

Pathogenic Variants in CHEK2 Are Associated With an Adverse Prognosis in Symptomatic Early-Onset Breast Cancer.

Greville-Heygate SL, Maishman T, Tapper WJ, Cutress RI, Copson E, Dunning AM, Haywood L, Jones LJ, Eccles DM. Greville-Heygate SL, et al. Among authors: copson e. JCO Precis Oncol. 2020 May 4;4:PO.19.00178. doi: 10.1200/PO.19.00178. eCollection 2020. JCO Precis Oncol. 2020. PMID: 32923877 Free PMC article.

2

Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers.

Copson ER, White HE, Blaydes JP, Robinson DO, Johnson PW, Eccles DM. Copson ER, et al. BMC Cancer. 2006 Mar 24;6:80. doi: 10.1186/1471-2407-6-80. BMC Cancer. 2006. PMID: 16563154 Free PMC article.

3

Prediction of single-nucleotide substitutions that result in exon skipping: identification of a splicing silencer in BRCA1 exon 6.

Raponi M, Kralovicova J, Copson E, Divina P, Eccles D, Johnson P, Baralle D, Vorechovsky I. Raponi M, et al. Among authors: copson e. Hum Mutat. 2011 Apr;32(4):436-44. doi: 10.1002/humu.21458. Epub 2011 Mar 8. Hum Mutat. 2011. PMID: 21309043

4

Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study.

Copson E, Eccles B, Maishman T, Gerty S, Stanton L, Cutress RI, Altman DG, Durcan L, Simmonds P, Lawrence G, Jones L, Bliss J, Eccles D; POSH Study Steering Group. Copson E, et al. J Natl Cancer Inst. 2013 Jul 3;105(13):978-88. doi: 10.1093/jnci/djt134. Epub 2013 May 30. J Natl Cancer Inst. 2013. PMID: 23723422

5

Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study.

Copson E, Maishman T, Gerty S, Eccles B, Stanton L, Cutress RI, Altman DG, Durcan L, Simmonds P, Jones L, Tapper W; POSH study steering group; Eccles D. Copson E, et al. Br J Cancer. 2014 Jan 7;110(1):230-41. doi: 10.1038/bjc.2013.650. Epub 2013 Oct 22. Br J Cancer. 2014. PMID: 24149174 Free PMC article.

6

Obesity and the outcome of young breast cancer patients in the UK: the POSH study.

Copson ER, Cutress RI, Maishman T, Eccles BK, Gerty S, Stanton L, Altman DG, Durcan L, Wong C, Simmonds PD, Jones L, Eccles DM; POSH Study Steering Group. Copson ER, et al. Ann Oncol. 2015 Jan;26(1):101-112. doi: 10.1093/annonc/mdu509. Epub 2014 Oct 30. Ann Oncol. 2015. PMID: 25361993 Free article.

7

An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis.

Maishman T, Copson E, Stanton L, Gerty S, Dicks E, Durcan L, Wishart GC, Pharoah P; POSH Steering Group; Eccles D. Maishman T, et al. Among authors: copson e. Br J Cancer. 2015 Mar 17;112(6):983-91. doi: 10.1038/bjc.2015.57. Br J Cancer. 2015. PMID: 25675148 Free PMC article.

8

Clinical proteomics and breast cancer.

Zeidan BA, Townsend PA, Garbis SD, Copson E, Cutress RI. Zeidan BA, et al. Among authors: copson e. Surgeon. 2015 Oct;13(5):271-8. doi: 10.1016/j.surge.2014.12.003. Epub 2015 Feb 24. Surgeon. 2015. PMID: 25736469 Review.

9

Obesity in breast cancer--what is the risk factor?

James FR, Wootton S, Jackson A, Wiseman M, Copson ER, Cutress RI. James FR, et al. Among authors: copson er. Eur J Cancer. 2015 Apr;51(6):705-20. doi: 10.1016/j.ejca.2015.01.057. Epub 2015 Mar 3. Eur J Cancer. 2015. PMID: 25747851 Review.

10

Family history and outcome of young patients with breast cancer in the UK (POSH study).

Eccles BK, Copson ER, Cutress RI, Maishman T, Altman DG, Simmonds P, Gerty SM, Durcan L, Stanton L, Eccles DM; POSH Study Steering Group. Eccles BK, et al. Among authors: copson er. Br J Surg. 2015 Jul;102(8):924-35. doi: 10.1002/bjs.9816. Epub 2015 May 20. Br J Surg. 2015. PMID: 25989914

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page